Clinical Trial Update: Objective, Passive Assessment of LRRK2 Carriers

View source ↗

Summary

This clinical trial update notes that the study on passive assessment of LRRK2 carriers in Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Rochester | Conditions: Parkinson Disease | Status: COMPLETED